Ensign Peak Advisors
NUVB icon

Ensign Peak Advisors’s Nuvation Bio NUVB Stock Holding History

Ensign Peak Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$95.2K Hold
22,200
– – ﹤0.01% 1581
2025
Q4 		$199K Buy
+22,200
New +$138K ﹤0.01% 1320
2024
Q1 		– Sell
-63,763
Closed -$96.3K – 1743
2023
Q4 		$96.3K Hold
63,763
– – ﹤0.01% 1730
2023
Q3 		$85.4K Hold
63,763
– – ﹤0.01% 1742
2023
Q2 		$115K Sell
63,763
-175,568
-73% -$298K ﹤0.01% 1746
2023
Q1 		$397K Buy
239,331
+3,206
+1% +$6.5K ﹤0.01% 1679
2022
Q4 		$453K Buy
236,125
+10,712
+5% +$21.7K ﹤0.01% 1642
2022
Q3 		$505K Sell
225,413
-15,333
-6% -$43.8K ﹤0.01% 1445
2022
Q2 		$780K Sell
240,746
-782,739
-76% -$3.41M ﹤0.01% 1251
2022
Q1 		$5.38M Sell
1,023,485
-134,385
-12% -$755K 0.01% 570
2021
Q4 		$9.84M Sell
1,157,870
-65,110
-5% -$598K 0.02% 481
2021
Q3 		$12.2M Buy
1,222,980
+35,428
+3% +$321K 0.03% 398
2021
Q2 		$11.1M Buy
1,187,552
+338,888
+40% +$3.86M 0.02% 409
2021
Q1 		$8.87M Buy
848,664
+500,000
+143% +$5.59M 0.02% 453
2020
Q4 		$4.08M Buy
+348,664
New +$3.63M 0.01% 689

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ensign Peak Advisors's NUVB Position: Q1 2026 in Review

Ensign Peak Advisors held its Nuvation Bio (NUVB) position steady in Q1 2026 at 22,200 shares worth $95.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1581.

Ensign Peak Advisors first reported a position in NUVB in Q4 2020 and has held it in 15 quarters since. The position peaked at $12.2M in Q3 2021. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Ensign Peak Advisors held 22,200 shares of Nuvation Bio worth $95.2K as of Q1 2026.
  • Ensign Peak Advisors left its Nuvation Bio share count unchanged in Q1 2026.
  • Nuvation Bio made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q1 2026, its #1581 holding.
  • Ensign Peak Advisors first reported a position in Nuvation Bio in Q4 2020 and has held it in 15 quarters since.
  • Ensign Peak Advisors's Nuvation Bio position peaked at $12.2M in Q3 2021.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.